What is Protalix BioTherapeutics, Inc. Common Stock's Market Cap?

Protalix BioTherapeutics, Inc. Common Stock's Market Cap is $213.5M, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Enterprise Value?

Protalix BioTherapeutics, Inc. Common Stock's Enterprise Value is $186.1M, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Trailing P/E?

Protalix BioTherapeutics, Inc. Common Stock's Trailing P/E is 11.3×, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Price / Sales?

Protalix BioTherapeutics, Inc. Common Stock's Price / Sales is 2.6×, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's EV / Revenue?

Protalix BioTherapeutics, Inc. Common Stock's EV / Revenue is 2.3×, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's EV / EBITDA?

Protalix BioTherapeutics, Inc. Common Stock's EV / EBITDA is 7.6×, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Revenue (TTM)?

Protalix BioTherapeutics, Inc. Common Stock's Revenue (TTM) is $80.6M, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Net Income (TTM)?

Protalix BioTherapeutics, Inc. Common Stock's Net Income (TTM) is $18.9M, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's EBITDA?

Protalix BioTherapeutics, Inc. Common Stock's EBITDA is $24.9M, based on as-reported figures from SEC (XBRL) filings.

What is Protalix BioTherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Protalix BioTherapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.24, based on as-reported figures from SEC (XBRL) filings.

Protalix BioTherapeutics, Inc. Common Stock (PLX) Financial Statements

Protalix BioTherapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001SBVMW4

XASE · usd

2.65▼ 0.02 (-0.75%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close2.67

Day's Range2.60 – 2.67

52-Week Range1.53 – 3.19

Volume907.6K

Avg Volume768.6K

Share Statistics

Shares Outstanding

Employees226

ExchangeXASE

Listed1996-01-02

Share count as of August 1, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Protalix BioTherapeutics, Inc. Common Stock (PLX)

What is Protalix BioTherapeutics, Inc. Common Stock's Market Cap?: Protalix BioTherapeutics, Inc. Common Stock's Market Cap is $213.5M, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Enterprise Value?: Protalix BioTherapeutics, Inc. Common Stock's Enterprise Value is $186.1M, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Trailing P/E?: Protalix BioTherapeutics, Inc. Common Stock's Trailing P/E is 11.3×, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Price / Sales?: Protalix BioTherapeutics, Inc. Common Stock's Price / Sales is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's EV / Revenue?: Protalix BioTherapeutics, Inc. Common Stock's EV / Revenue is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's EV / EBITDA?: Protalix BioTherapeutics, Inc. Common Stock's EV / EBITDA is 7.6×, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Revenue (TTM)?: Protalix BioTherapeutics, Inc. Common Stock's Revenue (TTM) is $80.6M, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Net Income (TTM)?: Protalix BioTherapeutics, Inc. Common Stock's Net Income (TTM) is $18.9M, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's EBITDA?: Protalix BioTherapeutics, Inc. Common Stock's EBITDA is $24.9M, based on as-reported figures from SEC (XBRL) filings.
What is Protalix BioTherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Protalix BioTherapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.24, based on as-reported figures from SEC (XBRL) filings.